to in utero asphyxial brain injury with consequences for postnatal health. (7),(8) 71 The main cause of fetal inflammation, chorioamnionitis, is a frequent (10% of all pregnancies, up to 40% 72 of preterm births) and often subclinical fetal inflammation associated with ~9fold increased risk for 73 cerebral palsy spectrum disorders with life lasting neurological deficits and an increased risk for acute or 74 life-long morbidity and mortality, inversely correlated with gestational age at delivery. (8), (9),(10) 75 In addition to short-term brain damage, recent studies suggest that neuroimmune responses to in utero 76 infection may also have long-term health consequences. In adults, exposure to inflammatory stimuli can 77 activate microglia (glial priming, reviewed in(11) , (12)). Confronted with a renewed inflammatory 78 stimulus, they can sustain chronic or exaggerated production of pro-inflammatory cytokines associated 79 with postnatal neuroinflammatory diseases such as Multiple Sclerosis or sustained cognitive dysfunction 80 ("second hit" hypothesis). (12), (13), (14) 81 α7 nicotinic acetylcholine receptor (α7nAChR) signaling in microglia may be involved in modulating 
RESULTS

92
Primary fetal sheep microglia culture 93 94 In vitro studies were conducted in primary cultures derived from six controls (naïve) and from two in vivo 95 LPS-exposed animals (SH) in 1-2 in vitro replicates each animal depending on cell numbers obtained The cytokine IL-1β secretion profile showed a non-random distribution pattern (p<0.001, main term 102 "group"), but not for the main term "SH yes or no" (p=0.122). The latter main term identified each group 103 as having or not having been exposed to an in vivo hit, i.e., testing for the SH effect on IL-1β secretion 104 profile without accounting for the experimental group. LPS exposure led to IL-1β rise (p=0.020) which 105 was non-randomly changed by α7nAChR agonism (p<0.001), but not by antagonism (p=0.801).
107
The GEE model exploring the contribution of the second hit to the IL-1β secretion profile revealed a 108 significant interaction between the four experimental groups (control, LPS, antagonist and agonist 109 pre-treatments) and the presence or absence of two hits (p<0.001 for interaction term "group"*"SH yes or 110 no"). Specifically, without the preceding in vivo hit, α7nAChR agonism reduced the effect of this 111 heightened IL-1β secretion (p=0.028). Surprisingly, with the preceding in vivo hit, i.e., in the SH groups, 112 α7nAChR agonism amplified the effect (p=0.028). That is, in vivo exposure to LPS reversed the effect of 113 the agonistic α7nAChR stimulation. Meanwhile, for α7nAChR antagonism the results were consistently 114 supporting the initial hypothesis with IL-1β rising when accounting in the model for the preceding 115 absence or presence of the in vivo first LPS hit (interaction terms "NB"* "SH yes or no" (p=0.048). We 116 found no significant interaction for NC and NL groups and SH (p=0.204).
118
RNAseq approach
120
Whole transcriptome analysis 121 We reported the genomic landscape of primary fetal sheep microglia in response to LPS using similar 122 quality control methods to confirm the cell culture purity.(18) Here we sequenced at high throughput the 123 whole transcriptome of microglia exposed to LPS and pre-incubated with α7nAChR agonist or antagonist 124 ( Figure 1A ). We performed a direct differential analysis of NA versus NB which eliminated the 125 background noise of NC. This approach allowed us to observe the immediate effect of LPS on microglial 126 transcriptome when it is modulated by α7nAChR antagonist versus agonist treatments. We performed 6 127 differential analyses of microglia exposed to agonist and antagonist (NA, NB, respectively) versus control 128 (NC) and second hit microglia exposed to antagonistic treatment (SHB). In Table 1 Figure 2C ).
162
Effect of α7nAChR agonist and antagonistic drugs on microglial transcriptome
163
Our main analysis focused on differences between NB and NA treatment. Our differential analysis of NA 164 versus NB revealed 162 DEG, among which 24 were upregulated and 138 were down regulated (Table 1) . 165 Gene ontology of DEG down regulated in NA versus NB showed that DE down regulated were associated 166 with the immune system (GO:0002376), however two DE up regulated genes also clustered for the GO 167 terms immune system, HSPA6 and GADD45G ( Figure 3B ). In the human genome, the gene HSPA6 codes 168 for the Heat shock 70 kDa protein 6, and GADD45G codes for Growth arrest and DNA damage-inducible 169 protein GADD45 gamma.
170
Interestingly, we noticed that GO terms such as Locomotion (GO:0040011) and Reproduction
171
(GO:0000003) were associated with DE down regulated genes ( Figure 3A ). We performed a second GO 172 analysis with ToppGene of DEG down regulated, selected significant GO terms clusters (P < 10 -3 ) and 173 represented these in a bar chart with -Log(P) (Figure 4 ). Among DEG down regulated, the immune 174 response was strongly significant (P = 6.10 x 10 -15 ); we also noticed leukocyte migration and 175 inflammatory response among the GO terms clustering (Figure 4 , Table 3 ).
176
Lending support to our hypothesis, these results confirmed the anti-inflammatory effect of the α7nAChR 177 agonistic stimulation on microglia. homeostasis and α7nAChR signaling in microglia (Fig. 7) . The model highlights in red three exogenous 325 factors that may be driving the microglial phenotype, some more intuitive (inflammation) than others (iron 326 and stress). We briefly outline below the mechanistic connections to the "non-intuitive" factors and refer 327 the interested reader to the cited references for details. The second major factor is the actual availability of α7nAChR agonists to drive this pathway. Figure legends antagonist-preincubated LPS-exposed naïve microglia (NB). Bar graph of 138 DEG down regulated.
533
Each selected GO term (P < 10 -3 ) was represented on a -Log (P) scale. 
a"
Figure" 5." DifferenJal" analysis" of" the" transcriptome" of" microglia" postTtreatment" with" the" antagonist" Bungaratoxin" and" the" agonist"ARTR17779."(a)"Microglia"treated"with"the"antagonist"Bungaratoxin"recruited"more"genes"involved"in"inflammatory" pathway." " We( iden<fied ( 1, 432( differen<ally( expressed( (DE, ( padj( <( 0.1)( up( regulated( genes( in( LPS( and( antagonist$exposed( microglia((NB) . (We(compared(the(popula<on(of(DE(up(regulated(genes(with(those(previously(iden<fied(in(LPS$exposed(microglia( (NL).(In(total, (1, 234(genes(were(unique(to(NB(and(analysis(of(pathways(with(Toppcluster(revealed(that(unique(genes(to(NB(are( members(of(the(Jak$STAT, (TNF$alpha(and(NFKB(signaling(pathways.((b) "Bungaratoxin"also"increased"the"response"in"DE"down" regulated"genes. Figure 5B.
Figure 5B. Pathways revealed by Gene Ontology of uniquely differentially expressed down regulated genes in SHB; pathways are represented with their -Log(P). Highlighted in red are the three exogenous factors that may be driving the microglial phenotype: inflammation, iron and stress. The former two stimulate hepcidin which in turn acts on ferroportin to be internalized and degraded. This reduces extracellular iron (sensed as Fe-TF, heme transferrin by TFR2, transferrin receptor 2 [shown here simplified as the representative iron sensor receptor] and increases the intracellular iron, a process referred to as iron sequestration. We propose that ferroportin's membrane localization appears to also be controlled by the α7nAChR signaling (blue arrow). α7nAChR signaling depends on the acetyl choline (ACh) availability. The latter depends on the afferent vagus nerve cholinergic signaling in the brain via a distributed network as well as the non-vagal sources of ACh controlled by ACh esterase (AChE) activity and the availability of dietary choline. Remarkably, a large body of research has shown that AChE activity depends on chronic stress levels, a factor highly relevant in fetal microglia context in particular, because stress is very common in pregnancy. Stress results in shifts of the post-translational modification of AChE from AChE-S splice variant (healthy) to the less stable AChE-R variant. Tables   Table 1. NC 
